1.	The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia Phase: Phase IV Type: Behavioral study, Biomarker/Laboratory analysis, Prevention Status: Completed Age: 16 to 65 Sponsor: Other Protocol IDs: MD-095-PP-05A, NCT00495352
2.	Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women? Phase: Phase III, Phase II Type: Behavioral study Status: Closed Age: 18 to 65 Sponsor: NCI, Other Protocol IDs: 1 R03 CA119747, NCT00420160
3.	Phase III Randomized Study of Smoking Cessation Intervention With or Without Bupropion in Patients With Completely Resected Stage I or II Non-Small Cell Lung Cancer Who are Current Smokers Phase: Phase III Type: Prevention Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-S0002, CALGB-79807, ECOG-S0002, NCI-P02-0215, NCT00032084
4.	Phase III Randomized Study of Nicotine Inhaler Versus Bupropion Versus Nicotine Inhaler Plus Bupropion for Smoking Cessation and Prevention of Relapse in Participants Who Currently Smoke Phase: Phase III Type: Prevention Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N99C4, NCI-P02-0220, NCT00033592
5.	Phase III Randomized Study of Behavioral Counseling and Nicotine-Replacement Therapy With Either Oral Nicotine Lozenge or Transdermal Nicotine Patch for Smoking Cessation in Adult Smokers Phase: Phase III Type: Behavioral study, Educational/Counseling/Training Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: FCCC-FCRB-04-003-P, FCRB-04-003-P, NCT00365508
6.	Smoking Cessation for Depressed Smokers Phase: Phase II, Phase I Type: Behavioral study, Educational/Counseling/Training, Prevention Status: Closed Age: 16 and over Sponsor: Other Protocol IDs: 2006-0351, NCT00494728
7.	Phase II Study of Nicotine Dermal Patch in Patients With Classic Kaposi's Sarcoma Phase: Phase II Type: Treatment Status: Completed Age: 18 to 78 Sponsor: NCI Protocol IDs: NCI-06-C-N033, NCT00295984
8.	Study to Evaluate the Reversion of Premalignant Markers Following Smoking Cessation in Patients at High Risk for Developing Lung Cancer (Summary Last Modified 08/97) Phase: No phase specified Type: Prevention Status: Closed Age: over 30 Sponsor: Other Protocol IDs: UCHSC-92385, NCI-V95-0644
9.	Randomized Study of Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Planning to Stop Smoking Phase: No phase specified Type: Prevention Status: Completed Age: 18 to 67 Sponsor: Other Protocol IDs: PICS-R44-CA80525, NCI-V01-1662, NCT00021138
10.	Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer Phase: No phase specified Type: Educational/Counseling/Training Status: Closed Age: 19 and over Sponsor: NCI, Other Protocol IDs: CDR0000078281, E-1Y92, NCI-P93-0042, NCT00002520
11.	Randomized Study of Behavioral Training With Versus Without Bupropion for Smoking Cessation and the Prevention of Relapse in Participants Who Are Current Smokers Phase: No phase specified Type: Prevention Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: SUMC-74511
12.	Smoking Cessation Intervention for Cancer Patients Phase: No phase specified Type: Behavioral study, Educational/Counseling/Training Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 02-094, NCT00575718
13.	Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking Phase: No phase specified Type: Behavioral study, Prevention Status: Closed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000616663, R01CA129226, BUTLER-0807-004, 0807-004, NCT00790569
14.	Nicotine Patch Pretreatment for Smoking Cessation in PTSD Phase: No phase specified Type: Behavioral study, Prevention Status: Closed Age: 18 to 70 Sponsor: Other Protocol IDs: NEUA-007-07F, NCT00625131